CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2005-02-22 | ARMSTRONG R DOUGLAS PHD Chairman and CEO | Option exercise | +125,000 | $0.38 | $48K | 705,879 |
| 2005-02-22 | ARMSTRONG R DOUGLAS PHD Chairman and CEO | Option exercise | +62,500 | $1.64 | $103K | 768,379 |
| 2005-02-22 | ARMSTRONG R DOUGLAS PHD Chairman and CEO | Option exercise | +300,000 | $0.40 | $120K | 1,068,379 |
| 2005-02-22 | ARMSTRONG R DOUGLAS PHD Chairman and CEO | Sale | −500 | $3.03 | $2K | 1,067,879 |
| 2005-02-22 | ARMSTRONG R DOUGLAS PHD Chairman and CEO | Sale | −14,942 | $3.02 | $45K | 1,052,937 |
| 2005-02-22 | ARMSTRONG R DOUGLAS PHD Chairman and CEO | Sale | −34,643 | $3.01 | $104K | 1,018,294 |
| 2005-02-22 | ARMSTRONG R DOUGLAS PHD Chairman and CEO | Sale | −119,508 | $3.00 | $359K | 898,786 |
| 2005-02-22 | ARMSTRONG R DOUGLAS PHD Chairman and CEO | Sale | −4,507 | $2.92 | $13K | 894,279 |
| 2005-02-22 | ARMSTRONG R DOUGLAS PHD Chairman and CEO | Option exercise · Stock Option (right to buy) | −118,518 | $0.84 | $100K | 198,482 |
| 2005-02-22 | ARMSTRONG R DOUGLAS PHD Chairman and CEO | Option exercise · Stock Option (right to buy)9/17/2011 | −142,188 | $1.05 | $149K | 600,000 |
| 2005-02-22 | ARMSTRONG R DOUGLAS PHD Chairman and CEO | Option exercise · Stock Option (right to buy) | +125,000 | $0.38 | $48K | 75,000 |
| 2005-02-22 | ARMSTRONG R DOUGLAS PHD Chairman and CEO | Option exercise · Stock Option (right to buy) | +62,500 | $1.64 | $103K | 137,500 |
| 2005-02-22 | ARMSTRONG R DOUGLAS PHD Chairman and CEO | Option exercise · Stock Option (right to buy) | +300,000 | $0.40 | $120K | 0 |
| 2005-02-16 | FINGERLE LINDA M Director | Purchase | +356 | $2.81 | $1K | 5,566 |
| 2005-01-19 | FINGERLE LINDA M Director | Purchase | +96 | $2.60 | $250 | 5,210 |
| 2004-12-22 | FINGERLE LINDA M Director | Purchase | +227 | $1.10 | $250 | 5,114 |
| 2004-12-20 | STAUBITZ ARTHUR Director | Grant or award · Stock Option (Right to buy) | +5,000 | $1.17 | $6K | 10,000 |
| 2004-11-17 | FINGERLE LINDA M Director | Purchase | +262 | $0.95 | $249 | 4,887 |
| 2004-11-10 | Hock Janet Mary Vice President Global Research | Grant or award · Stock Option (right to buy) | +150,000 | $1.05 | $158K | 0 |
| 2004-11-10 | FINGERLE LINDA M Director | Grant or award · Stock Option (right to buy) | +12,000 | $1.05 | $13K | 4,625 |
Page 79 of 81 · 1,618 trades